[APLS] YoY Quarter Result on 30-Jun-2021 [#Q2]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
09-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -19.35%
YoY- -84.79%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 199,685 94,969 16,322 623 0 0 0 -
PBT -37,543 -121,843 -155,491 -219,191 -118,617 -71,090 -33,334 1.99%
Tax 114 194 486 3,706 6,914 388 -33,669 -
NP -37,657 -122,037 -155,977 -219,191 -118,617 -71,090 -33,334 2.05%
Tax Rate - - - - - - - -
Total Cost 237,342 217,006 172,299 219,814 118,617 71,090 33,334 38.66%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -18.86 -128.50 -955.62 -35,183.15 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.30 -1.02 -1.46 -2.72 -1.57 -1.12 -0.61 -11.14%
EPS Diluted -0.30 -1.02 -1.46 -2.72 -1.57 -1.12 -0.61 -11.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.